---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020719"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:51:12.201702+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "medium"
source: SEC EDGAR
---

# RenovoRx shareholders elect all 7 director nominees and ratify auditor at 2023 annual meeting

## Summary
- Each of the 7 director nominees received over 5 million votes for, with Ramtin Agah, M.D. and Shaun R. Bagai each getting 5,094,179 for.
- Ratification of Baker Tilly US, LLP as independent auditor for FY2023 passed with 7,463,474 votes for, 22,982 against.
- Broker non-votes totaled 2,374,191 on director elections; no broker non-votes on auditor ratification.

## SEC filing metadata
- accession: 0001493152-23-020719
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: medium
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315223020719/0001493152-23-020719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315223020719/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020719
- JSON: https://secwatch.observer/filing/0001493152-23-020719.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020719.txt

## Key facts
- Shareholder Votes
  RenovoRx, Inc. shareholders approved Election of Directors at the 2023-06-08 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal 1: Election of Directors Name of Director For Withheld Broker Non-Votes Ramtin Agah, M.D. 5,094,179 19,343 2,374,191 Shaun R. Bagai 5,094,179 19,343 2,374,191 David Diamond 5,107,063 6,459 2,374,191 Kirsten Angela Macfarlane 5,106,837 6,685 2,374,191 Laurence J. Marton, M.D. 5,068,635 44,887 2,374,191 Una S. Ryan, O.B.E., Ph.D., D.Sc. 5,053,096 60,426 2,374,191 Robert J. Spiegel, M.D., FACP 5,013,634 99,888 2,374,191 Each director nominee was duly elected to serve until the 2024 Annual Meeting of Stockholders and until their successor is duly elected and qualified, subject to their earlier resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315223020719/0001493152-23-020719-index.htm
- Shareholder Votes
  RenovoRx, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2023-06-08 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 7,463,474 22,982 1,257 0 The stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315223020719/0001493152-23-020719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.